If you’ve tried multiple therapies for PTSD—SSRIs that dulled your emotions without touching the nightmares, exposure therapy that felt retraumatizing, medications that promised relief but delivered side effects instead—you’re not alone, and you’re not out of options. Ketamine-assisted therapy represents a fundamentally different approach to treating PTSD, one that works with your brain’s natural capacity for healing rather than simply suppressing symptoms. Research shows that ketamine can reduce PTSD symptoms comparably to FDA-approved medications, but it works faster and through different mechanisms, particularly when combined with trauma-focused psychotherapy (Sicignano et al., 2024).
What Makes PTSD “Treatment-Resistant”
Treatment-resistant PTSD typically means you’ve tried at least two evidence-based treatments—usually SSRIs and trauma-focused therapy like prolonged exposure or cognitive processing therapy—without achieving significant symptom reduction or remission. Approximately 40-50% of people with PTSD don’t respond adequately to first-line treatments, and even among those who do respond, many remain symptomatic years after treatment (Ragnhildstveit et al., 2023).
This isn’t a reflection of your effort or willingness to heal. PTSD treatment resistance often stems from how trauma fundamentally alters brain circuitry. Chronic PTSD creates synaptic loss in the prefrontal cortex, overactivity in the amygdala, and persistent dysregulation in the brain networks responsible for fear extinction and emotional regulation. Traditional antidepressants work primarily on serotonin pathways, which can help with comorbid depression but often don’t address the core glutamate system dysfunction underlying PTSD.
In Sacramento’s veteran and first responder communities, we also see how moral injury—the psychological damage from actions or inactions that violated deeply held values—adds layers of complexity that standard PTSD treatments weren’t designed to address. When guilt and shame are central to the trauma, cognitive reframing alone often feels inadequate.
How Ketamine Works Differently Than Traditional PTSD Treatments
Ketamine is an NMDA receptor antagonist, meaning it works on the glutamate system—the brain’s primary excitatory neurotransmitter involved in learning, memory formation, and synaptic plasticity. While SSRIs take weeks to months to produce effects by slowly increasing serotonin availability, ketamine produces rapid changes in neural connectivity within hours.
At the molecular level, ketamine triggers a cascade of events. It blocks NMDA receptors on inhibitory interneurons, leading to a surge of glutamate release. This glutamate activates AMPA receptors, which in turn triggers the release of brain-derived neurotrophic factor (BDNF). BDNF is essentially fertilizer for your brain—it promotes the growth of new synaptic connections, particularly in the prefrontal cortex and hippocampus, regions often damaged by chronic trauma (Ragnhildstveit et al., 2023).
This neuroplasticity—the brain’s ability to form new neural pathways—is crucial for PTSD recovery. Trauma creates rigid, overlearned fear responses. Your brain has formed strong connections between certain triggers and the alarm response. Ketamine temporarily increases neural flexibility, creating what researchers call a “critical period of heightened plasticity” where those old patterns become more malleable and new, healthier responses can be encoded.
Additionally, ketamine affects several brain regions central to PTSD:
The amygdala (fear center): Ketamine reduces hyperactivity here, which may explain the rapid reduction in hypervigilance, startle response, and intrusive memories that many patients experience.
The hippocampus (memory consolidation): By promoting BDNF and synaptogenesis, ketamine may help with the contextual processing of traumatic memories—helping your brain understand that what happened then doesn’t predict what’s happening now.
The prefrontal cortex (executive function and emotional regulation): Strengthening connections here supports better top-down control of fear responses and improved ability to inhibit the amygdala when it overreacts.
What the Research Shows About Ketamine for PTSD
A systematic review and meta-analysis examining multiple randomized controlled trials found that ketamine provided a mean difference in CAPS scores (the gold-standard clinician-administered PTSD scale) of -10.6 units compared to control—an effect size comparable to FDA-approved medications sertraline and paroxetine. Importantly, these improvements appeared rapidly, with significant symptom reduction evident at 24 hours post-treatment and maintained at weeks 1, 2, and 4 (Sicignano et al., 2024).
Another comprehensive review of 26 studies spanning case reports through randomized trials noted encouraging signals of therapeutic safety, efficacy, and durability, particularly for chronic, refractory PTSD cases that hadn’t responded to conventional treatments (Ragnhildstveit et al., 2023). Time to relapse was extended by an average of 15.74 days compared to control treatments.
However, research also reveals an important nuance: ketamine combined with trauma-focused psychotherapy produces significantly better outcomes than ketamine alone. A meta-analysis of combined treatment studies found pooled symptom reductions of -7.26 on the CAPS and -5.17 on the PCL (self-report PTSD checklist), suggesting that integration with therapy extends and amplifies ketamine’s effects (Pradhan et al., 2022).
This is why at ShaMynds, we emphasize the “assisted” in ketamine-assisted therapy. The ketamine opens a window of neuroplasticity, but what happens during and after that window—the therapeutic work, the processing, the integration—determines whether change is temporary or lasting.
The Role of Integration: Why Therapy Matters
Ketamine alone creates the neurobiological conditions for change. Trauma-focused psychotherapy provides the content and direction for that change. Think of ketamine as tilling the soil—making it receptive—while therapy is planting the seeds of new patterns.
During the heightened neuroplasticity period following ketamine administration (which peaks 24 hours post-treatment and continues for several days), your brain is primed for new learning. This is the optimal time for trauma processing work. Studies combining ketamine with therapies like TIMBER (Trauma Interventions using Mindfulness Based Extinction and Reconsolidation) or prolonged exposure found that psychotherapy administered during this window extended the duration of symptom relief from roughly two weeks with ketamine alone to over a month with combined treatment (Pradhan et al., 2022).
At ShaMynds, our integrative approach combines ketamine treatment with evidence-based modalities including EMDR, Internal Family Systems, and somatic therapy. Our therapists are specifically trained in psychedelic-assisted therapy through the Integrative Psychiatry Institute, understanding how to work with non-ordinary states of consciousness to facilitate deep trauma processing.
Administration Methods and Treatment Protocols
Ketamine for PTSD is typically administered in several ways, each with distinct characteristics:
Intravenous (IV) infusion over 40-60 minutes is the most researched route. This provides precise dosing and blood level control. Most protocols involve a series of six infusions over 3-7 weeks for the induction phase, followed by maintenance treatments as needed.
Intramuscular (IM) injection provides a somewhat more intense experience with faster onset.
Sublingual or nasal administration offers more gradual onset and lower intensity, which some patients prefer, though bioavailability is lower so effects may be less pronounced.
The experience during treatment is often described as dissociative—a sense of being an observer of your thoughts and body rather than fully identified with them. This temporary detachment from your ordinary defensive patterns can allow you to approach traumatic material differently, with less reactivity. Some patients report visual changes, alterations in time perception, or feelings of expansiveness. These experiences are temporary, typically resolving within an hour or two, and are monitored throughout by medical professionals.
Addressing Common Concerns: Cost and Time Investment
We understand that considering ketamine therapy raises practical questions. Treatment costs typically range from $450-$750 per session, with most insurance plans not yet covering ketamine for PTSD (though coverage is evolving). At ShaMynds, we provide reimbursement documentation (Superbills) for out-of-network benefits. PPOs may reimburse a percentage for all but the medicine itself.
The time investment for initial treatment is typically over 3-7 weeks, with each of the ketamine visits lasting approximately 2 hours including preparation, the infusion itself, and integration. You’ll need someone to drive you home, as you cannot operate a vehicle the day of treatment. For many patients, especially those who’ve spent years or decades trying other treatments, the concentrated nature of ketamine therapy—weeks rather than months or years—represents an efficient use of time.
Regarding efficacy: results vary by individual, and ketamine isn’t effective for everyone. However, research suggests approximately 70+% of people experience meaningful symptom reduction. For many, this represents the first significant relief after years of treatment resistance.
Is Ketamine-Assisted Therapy Right for You?
Ketamine may be particularly worth considering if you:
- Have tried at least two evidence-based PTSD treatments without adequate response
- Experience persistent intrusive memories, nightmares, or avoidance behaviors despite treatment
- Struggle with comorbid depression that hasn’t responded to antidepressants
- Are open to working with altered states of consciousness as part of healing
- Can commit to the integration work alongside ketamine sessions
- Don’t have contraindications such as uncontrolled hypertension, active psychosis, or certain cardiac conditions
The comprehensive evaluation process at ShaMynds includes medical history review, psychiatric assessment, and discussion of treatment goals to determine whether ketamine-assisted therapy aligns with your needs and circumstances. Our team—which includes board-certified physicians with fellowship training in integrative psychiatry and certifications in psychedelic-assisted therapy, working alongside licensed therapists specializing in trauma—provides coordinated care throughout your treatment journey.
Three Questions to Reflect On This Week
-
What has traditional treatment addressed, and what remains untouched?
Make a list. Often people find that cognitive symptoms improve but physical symptoms (hypervigilance, startle, somatic manifestations) persist. Or that depression lifted but avoidance patterns remain. This clarity helps you articulate what you’re still seeking from treatment.
-
What role does your body play in your PTSD?
Do you experience chronic tension, pain, or numbness? Do you dissociate? Understanding the somatic component of your PTSD can help you recognize whether body-centered approaches might be valuable.
-
What would meaningful improvement look like for you?
Not complete symptom elimination—that’s rarely realistic—but what would “better” feel like? Fewer nightmares? Less time lost to avoidance? Ability to be present with loved ones? Specific goals guide treatment planning.
Moving Forward
If you’ve been living with treatment-resistant PTSD, the landscape of therapeutic options has expanded significantly in recent years. Ketamine-assisted therapy, particularly when integrated with trauma-focused psychotherapy and body-centered practices, offers a pathway that works with your brain’s natural healing capacity rather than simply managing symptoms.
We offer free consultations at ShaMynds to discuss whether our integrative approach might be appropriate for your situation. Located in Midtown Sacramento, we serve individuals throughout Northern California, with particular expertise working with the veteran, first responder, and healthcare communities. We understand the nature of occupational trauma and moral injury, and we’ve designed our approach to honor both the courage it takes to seek help and the complexity of healing from experiences that challenged your sense of self and safety.
Your past treatments haven’t failed. They’ve been data points, showing you what doesn’t work so you can make informed decisions about what to try next. Ketamine-assisted therapy may or may not be that next step for you, but you deserve to make that choice with comprehensive, evidence-based information.
References
Pradhan, B., Parikh, T., Makani, R., & Sahoo, M. (2022). Combining Ketamine and Psychotherapy for the Treatment of Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. The Journal of Clinical Psychiatry, 86(4), 22m14503. https://www.psychiatrist.com/jcp/ketamine-plus-psychotherapy-for-ptsd/
Ragnhildstveit, A., Roscoe, J., Bass, L.C., Averill, C.L., Abdallah, C.G., & Averill, L.A. (2023). The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence. Therapeutic Advances in Psychopharmacology, 13, 20451253231154125. https://journals.sagepub.com/doi/10.1177/20451253231154125
Sicignano, D.J., Kurschner, R., Weisman, N., Sedensky, A., Hernandez, A.V., & White, C.M. (2024). The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses. Annals of Pharmacotherapy, 58(2), 179-192. https://journals.sagepub.com/doi/10.1177/10600280231199666